These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3135357)

  • 1. [Long-term observation for immunogenicity of plasma-derived hepatitis B vaccine and supplementary vaccination of recombinant vaccine in infants].
    Hayashi J; Kashiwagi S; Noguchi A; Ikematsu H; Nomura H; Kajiyama W; Ikeda K; Tamori K; Aoyama T
    Kansenshogaku Zasshi; 1988 Apr; 62(4):349-54. PubMed ID: 3135357
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody response to hepatitis B vaccination.
    Waldron HA
    Br J Ind Med; 1990 May; 47(5):354-5. PubMed ID: 2141533
    [No Abstract]   [Full Text] [Related]  

  • 3. Active pre-exposure immunisation against hepatitis B virus: immunogenicity of hepatitis B vaccine in healthy Thai adults and children.
    Pongpipat D; Suvatte V; Assateerawatts A; Bhethraratt S
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):63-5. PubMed ID: 2956961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [H-B-VAX II hepatitis B vaccine (recombinant) produced at the MSD Research Laboratories. Description of the vaccine].
    Przegl Epidemiol; 1991; 45(1-2):3-10. PubMed ID: 1839076
    [No Abstract]   [Full Text] [Related]  

  • 5. [The vaccine for hepatitis B virus. Definition of criteria for its use].
    Sturm JA
    Rev Paul Med; 1985; 103(1):23-31. PubMed ID: 2994199
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term observation on the immunogenicity of hepatitis B vaccine in infants and adults].
    Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H; Shingu T
    Kansenshogaku Zasshi; 1986 Jul; 60(7):659-65. PubMed ID: 3097205
    [No Abstract]   [Full Text] [Related]  

  • 7. Heat stability of a recombinant DNA hepatitis B vaccine.
    Van Damme P; Cramm M; Safary A; Vandepapelière P; Meheus A
    Vaccine; 1992; 10(6):366-7. PubMed ID: 1534639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccination against hepatitis B virus].
    Descos B
    Pediatrie; 1990; 45(3):173-9. PubMed ID: 2160641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of children with malignant diseases with alum-absorbed hepatitis B vaccine--Immunogenicity studies.
    Arnold W; Baumann W
    Scand J Infect Dis Suppl; 1983; 38():33-6. PubMed ID: 6580724
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness.
    Stephenne J
    Vaccine; 1988 Aug; 6(4):299-303. PubMed ID: 2973187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunogenicity and safety of hepatitis B virus vaccine].
    Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H; Aoyama T
    Kansenshogaku Zasshi; 1985 Oct; 59(10):970-6. PubMed ID: 3936888
    [No Abstract]   [Full Text] [Related]  

  • 13. [Active preventive vaccination against hepatitis B].
    Jilg W
    Internist (Berl); 1985 Oct; 26(10):633-9. PubMed ID: 2934346
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenicity of a recombinant, yeast-derived, anti-hepatitis-B vaccine after alternative dosage and schedule vaccination in Pakistani children.
    Akram DS; Maqbool S; Khan DS; Jafri R; Randhawa S; Valenzuela-Silva C; Lopez-Saura P
    Vaccine; 2005 Dec; 23(50):5792-7. PubMed ID: 16303217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B vaccine set for introduction into national immunization programs.
    Infect Control Hosp Epidemiol; 1992 Jun; 13(6):372. PubMed ID: 1535642
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers.
    Lee CY; Huang LM; Chang MH; Hsu CY; Wu SJ; Sung JL; Safary A
    Pediatr Infect Dis J; 1991 Apr; 10(4):299-303. PubMed ID: 1829515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience.
    van den Ende C; Marano C; van Ahee A; Bunge EM; De Moerlooze L
    Expert Rev Vaccines; 2017 Aug; 16(8):789-809. PubMed ID: 28586278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to intradermal hepatitis B vaccination: differences between males and females?
    Senden TF
    Vaccine; 1990 Dec; 8(6):612-3. PubMed ID: 2087882
    [No Abstract]   [Full Text] [Related]  

  • 20. The dose of hepatitis B vaccine.
    Seville P
    N Z Med J; 1988 Nov; 101(857):774. PubMed ID: 2972946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.